Christopher M Celano1, Rachel A Millstein2, C Andres Bedoya2, Brian C Healy3, Annelieke M Roest4, Jeff C Huffman5. 1. Department of Psychiatry, Massachusetts General Hospital, Boston, MA; Harvard Medical School, Boston, MA. Electronic address: ccelano@partners.org. 2. Department of Psychiatry, Massachusetts General Hospital, Boston, MA; Harvard Medical School, Boston, MA. 3. Harvard Medical School, Boston, MA; Department of Neurology, Massachusetts General Hospital, Boston, MA. 4. Interdisciplinary Center Psychopathology and Emotion Regulation, Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. 5. Department of Psychiatry, Massachusetts General Hospital, Boston, MA; Department of Neurology, Massachusetts General Hospital, Boston, MA.
Abstract
BACKGROUND: Depression and anxiety are common in patients with coronary artery disease (CAD). Although depression clearly has been associated with mortality in this population, the relationship between anxiety and mortality is less clear. Accordingly, we performed a series of meta-analyses to (1) examine the relationship between anxiety and mortality in patients with established CAD and (2) determine if this relationship differs in patients with stable CAD compared to those who have just had an acute coronary syndrome (ACS). METHODS AND RESULTS: Systematic literature searches identified 44 articles (total N = 30,527) evaluating the prospective relationship between anxiety and mortality in individuals with established CAD. A series of 8 adjusted and unadjusted meta-analyses were performed to examine this relationship across all patients, with sensitivity analyses completed in post-ACS and stable CAD cohorts. In unadjusted analyses, anxiety was associated with a moderate increase in mortality risk (odds ratio 1.21 per SD increase in anxiety). However, when adjusting for covariates, nearly all associations became nonsignificant. In sensitivity analyses, anxiety was associated with an increased risk of poor outcomes in the stable CAD-but not post-ACS-cohort. CONCLUSIONS: These analyses confirm that anxiety is associated with increased risk of mortality in patients with CAD; however, this relationship is not as strong as that of depression and may be explained partly by other clinical factors. If anxiety screening is performed, it should be performed during a period of clinical stability and should target anxiety disorders rather than anxiety symptoms alone.
BACKGROUND:Depression and anxiety are common in patients with coronary artery disease (CAD). Although depression clearly has been associated with mortality in this population, the relationship between anxiety and mortality is less clear. Accordingly, we performed a series of meta-analyses to (1) examine the relationship between anxiety and mortality in patients with established CAD and (2) determine if this relationship differs in patients with stable CAD compared to those who have just had an acute coronary syndrome (ACS). METHODS AND RESULTS: Systematic literature searches identified 44 articles (total N = 30,527) evaluating the prospective relationship between anxiety and mortality in individuals with established CAD. A series of 8 adjusted and unadjusted meta-analyses were performed to examine this relationship across all patients, with sensitivity analyses completed in post-ACS and stable CAD cohorts. In unadjusted analyses, anxiety was associated with a moderate increase in mortality risk (odds ratio 1.21 per SD increase in anxiety). However, when adjusting for covariates, nearly all associations became nonsignificant. In sensitivity analyses, anxiety was associated with an increased risk of poor outcomes in the stable CAD-but not post-ACS-cohort. CONCLUSIONS: These analyses confirm that anxiety is associated with increased risk of mortality in patients with CAD; however, this relationship is not as strong as that of depression and may be explained partly by other clinical factors. If anxiety screening is performed, it should be performed during a period of clinical stability and should target anxiety disorders rather than anxiety symptoms alone.
Authors: Johan Denollet; Elisabeth J Martens; Ivan Nyklícek; Viviane M Conraads; Beatrice de Gelder Journal: Health Psychol Date: 2008-05 Impact factor: 4.267
Authors: Chris Dickens; Linda McGowan; Carol Percival; Barbara Tomenson; Lawrence Cotter; Anthony Heagerty; Francis Creed Journal: Psychosom Med Date: 2008-04-23 Impact factor: 4.312
Authors: Mirela Habibović; Susanne S Pedersen; Krista C van den Broek; Dominic A M J Theuns; Luc Jordaens; Pepijn H van der Voort; Marco Alings; Johan Denollet Journal: Psychosom Med Date: 2012-11-28 Impact factor: 4.312
Authors: Lana L Watkins; Gary G Koch; Andrew Sherwood; James A Blumenthal; Jonathan R T Davidson; Christopher O'Connor; Michael H Sketch Journal: J Am Heart Assoc Date: 2013-03-19 Impact factor: 5.501
Authors: Caroline Andonian; Jürgen Beckmann; Sabina Biber; Peter Ewert; Sebastian Freilinger; Harald Kaemmerer; Renate Oberhoffer; Lars Pieper; Rhoia Clara Neidenbach Journal: Cardiovasc Diagn Ther Date: 2018-12
Authors: Christopher M Celano; Ana C Villegas; Ariana M Albanese; Hanna K Gaggin; Jeff C Huffman Journal: Harv Rev Psychiatry Date: 2018 Jul/Aug Impact factor: 3.732
Authors: Christopher M Celano; Eleanor E Beale; Scott R Beach; Arianna M Belcher; Laura Suarez; Shweta R Motiwala; Parul U Gandhi; Hanna Gaggin; James L Januzzi; Brian C Healy; Jeff C Huffman Journal: Psychosom Med Date: 2017-04 Impact factor: 4.312
Authors: Patrick J Smith; Andrew Sherwood; Stephanie Mabe; Lana Watkins; Alan Hinderliter; James A Blumenthal Journal: Gen Hosp Psychiatry Date: 2017-11 Impact factor: 3.238
Authors: Ryan Saelee; Viola Vaccarino; Samaah Sullivan; Muhammad Hammadah; Amit Shah; Kobina Wilmot; Naser Abdelhadi; Lisa Elon; Pratik Pimple; Belal Kaseer; Oleksiy Levantsevych; J D Bremner; Tené T Lewis Journal: J Psychosom Res Date: 2019-07-19 Impact factor: 3.006
Authors: Christopher M Celano; Daniel J Daunis; Hermioni N Lokko; Kirsti A Campbell; Jeff C Huffman Journal: Curr Psychiatry Rep Date: 2016-11 Impact factor: 5.285